Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants;Ostéonécrose maxillaire sous bisphosphonates et implants dentaires

Revue de Stomatologie et de Chirurgie Maxillo-Faciale

Volumn 108, Issue 6, 2007, Pages 555-558

  Savoldelli, C ^a   Le Page, F ^a   Santini, J ^a   Scortecci, G ^b   Odin, G ^a  

^a PASTEUR HOSPITAL   (France)

^b NONE   (France)

Author keywords

Bisphosphonates; Dental implants; Osteonecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ACTINOMYCOSIS; AGED; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; GINGIVA DISEASE; HUMAN; JAW DISEASE; MALE; MICROBIOLOGY; MOUTH ULCER; TOOTH IMPLANTATION;

ACTINOMYCOSIS; AGED; BONE DENSITY CONSERVATION AGENTS; DENTAL IMPLANTS; DIPHOSPHONATES; GINGIVAL DISEASES; HUMANS; MALE; MAXILLARY DISEASES; ORAL ULCER; OSTEONECROSIS;

EID: 36448986788     PISSN: 00351768     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stomax.2007.05.001     Document Type: Article

References (10)

1. Coleman R.E. Bisphosphonates: clinical experience. Oncologist 9 (2004) 14-27
2. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonates-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors? Recognition, prevention, and treatment. J. Oral Maxillofac. Surg. 63 (2005) 1567-1575 [Comment in: J. Evid. Based Dent Pract. 2006;6:283-4. J. Oral Maxillofac. Surg. 2006;64:1177. J. Oral Maxillofac. Surg. 2007;65:363-4]
3. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopoulos I., Bozas G., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence risk factors. J. Clin. Oncol. 23 (2005) 8580-8587
4. Hugentobler M., and Richter M. Proposition d'un algorithme de prise en charge médicodentaire pour les patients traités par bisphosphonates. Rev. Stomatol. Chir. Maxillofac. 107 (2006) 441-444
5. Meer S., Coleman H., Altini M., and Alexander T. Mandibular osteomyelitis and tooth exfoliation following zoster-CMV co-infection. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101 (2006) 70-75
6. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102 (2006) 433-441
7. Woeller A., Gering A., Brix M., Bettega G., and Lebeau J. Ostéonécrose des maxillaires sous bisphosphonates : cinq cas. Rev. Stomatol. Chir. Maxillofac. 107 (2006) 417-422
8. Garg A.K. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants. Dent. Implantol. Update 17 (2006) 73-78
9. Rodan G.A., and Fleisch H.A. Bisphosphonates:mechanisms of action. J. Clin. Invest. 97 (1996) 2692-2696
10. Mashiba T., Turner C.H., Hirano T., Forwood M.R., Johnston C.C., and Burr D.B. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28 (2001) 524-531